Option Players Pounce On PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics, Inc. (PTCT) is on fire, after the company said its drug still warrants a U.S. marketing application

Oct 16, 2015 at 11:25 AM
facebook X logo linkedin


PTC Therapeutics, Inc.'s (NASDAQ:PTCT) experimental muscle disorder drug failed to meet the primary goal of a late-stage trial, but the company said the results still support a U.S. marketing application. As such, the shares, which were down as much as 16% in overnight trading, were last seen up 2.7% at $32.62. Amid this volatility, traders are rushing PTCT's options pits.

Taking a step back, analysts have been quick to weigh in on the stock, following the disappointing data. Specifically, RBC, Oppenheimer, J.P. Morgan Securities, and Wedbush each slashed their price targets overnight. This is an unusual show of skepticism for an equity that sports "buy" ratings from 88% of covering analysts, and a consensus 12-month price target of $98 -- more than triple current levels.

As alluded to, option activity is blowing up this morning. Roughly 24,000 puts are on the tape, representing 20 times the expected amount for this point in the day. Digging deeper, eleventh-hour traders are eyeing the deep out-of-the-money October 25 put (which expires at tonight's close), while longer-term bettors have their sights set on the December 20 put -- the most active thus far. The 20-strike puts will move into the money if PTCT breaches $20 -- and hits record lows -- by options expiration on Friday, Dec. 18.

One group that can't be happy with PTC Therapeutics, Inc.'s (NASDAQ:PTCT) reversal higher is short sellers. A lofty 19% of the stock's float is sold short, representing six sessions' worth of activity, at typical volumes. This really shouldn't come as a surprise, though. Despite PTCT's intraday gain, it remains 36% lower on a year-to-date basis.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI